<?xml version="1.0" encoding="UTF-8"?>
<ref id="B249-pharmaceuticals-14-00381">
 <label>249.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zhong</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis</article-title>
  <source>Antivir. Res.</source>
  <year>2019</year>
  <volume>167</volume>
  <fpage>98</fpage>
  <lpage>103</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2019.04.011</pub-id>
  <?supplied-pmid 31034848?>
  <pub-id pub-id-type="pmid">31034848</pub-id>
 </element-citation>
</ref>
